General Information of the Compound
| Compound ID |
CP0449784
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]quinoline-8-sulfonamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H26Cl2N4O2S
|
||||||||||||||||||
| Molecular Weight |
493.46
|
||||||||||||||||||
| Canonical SMILES |
Clc1cccc(N2CCN(CCCCNS(=O)(=O)c3cccc4cccnc34)CC2)c1Cl
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H26Cl2N4O2S/c24-19-8-4-9-20(22(19)25)29-16-14-28(15-17-29)13-2-1-12-27-32(30,31)21-10-3-6-18-7-5-11-26-23(18)21/h3-11,27H,1-2,12-17H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZQUOAIISQYYMQZ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT00941, 5-hydroxytryptamine receptor 7